Project Grant HT94252410958
Award Date
11/15/24
Completion Date
11/14/27
Dollars Obligated
$1.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
The Department of the Army Medical Command awarded a $3.2 million Project Grant to The Trustees of Columbia University in New York, New York to support research titled "NOVEL EXPOSOMICS AND EXTRACELLULAR VESICLE BIOMARKERS TO UNRAVEL GENE - ENVIRONMENT INTERACTIONS AND MECHANISMS OF NEURODEGENERATION IN PARKINSON'S DISEASE." The grant period runs from September 1, 2022 to August 31, 2025.
The funding supports research under the Military Medical Research and Development program (CFDA...
The Department of the Army Medical Command awarded a $1,440,764 Project Grant to The Trustees of Columbia University in New York, New York to support research titled "NOVEL EXPOSOMICS AND EXTRACELLULAR VESICLE BIOMARKERS TO UNRAVEL GENE - ENVIRONMENT INTERACTIONS AND MECHANISMS OF NEURODEGENERATION IN PARKINSON'S DISEASE." The grant is funded under the Military Medical Research and Development program (CFDA 12.420) and aims to transform military and public health care through...
The Trustees of Columbia University in the City of New York will receive $1,619,986 from the Department of the Army Medical Command under a two-year Project Grant award to support preclinical characterization of Prosetin, a brain-penetrant MAP4K inhibitor for treating ALS. The grant was awarded on May 1, 2021 under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care...
The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, received a $567,654 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This funding supports spatial profiling of early, osimertinib-resistant brain lesions in EGFR-mutant lung cancer models over the 2-year period from July 1, 2023 to June 30, 2025. Through this grant, Columbia University will conduct biomedical...
The Trustees of Columbia University in New York City will receive $809,262 from the Department of the Army Medical Command under a Project Grant award to support preclinical characterization of AZVIII-7-18, a novel Paullone derivative for the treatment of ALS. The funding period is from July 1, 2022 to June 30, 2024.
The award is being made through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research aimed at...
The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, was awarded a $656,272 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at optimizing PD-1 immunotherapy through increased T cell regeneration and reduced antigen load. This 2-year project will be conducted in New York, NY from September 1, 2023 to August 31, 2025. The Military Medical...
The Trustees of Columbia University in the City of New York (Columbia University) was awarded a $658,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 targeting inflammatory signals as therapeutic strategies for peripheral T-cell lymphoma. Through this award, Columbia University will investigate medical solutions for lymphoma, a type of cancer...
This $1,199,967 Project Grant awarded on September 1, 2023 by the Defense Health Agency supports research under the Military Medical Research and Development (CFDA 12.420) program. The primary award recipient, the University of Vermont & State Agricultural College, will investigate "Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease". Two sub-awards were made to Case Western Reserve University and the Portland VA...
The Trustees of Columbia University in New York City will receive $486,000 from the Defense Health Agency through March 2024 to analyze the adaptive and innate immune response in patients with amyotrophic lateral sclerosis (ALS) who have been treated with antisense oligonucleotides. This Project Grant was awarded on April 1, 2021 under the Military Medical Research and Development program (CFDA 12.420).
The Defense Health Agency's Military Medical Research and Development program aims to...
This federal Project Grant award for $197,400.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the "DEVELOPMENT OF PATIENT-DERIVED CNS METASTASIS MODELS WITH STK11 INACTIVATION FOR DRUG DISCOVERY" at The Trustees of Columbia University in the City of New York.
The funding will enable Columbia University's Health Sciences Division to conduct research aimed at developing innovative patient-derived central...